Search results for: 'acquisition teva and agreements in pharma'
- Did you mean
 - acquisition term and agreements in pharma
 
- Related search terms
 - Acquisition Terms and Agreements in Pharma
 - acquisition texas and agreements in pharma
 - acquisition term and agreements in pharma
 - acquisition tech and agreements in pharma
 - acquisitions terms and agreements in pharma
 
- 
                
                    
                    Hematology Collaboration and Licensing Deals 2016-2025October 2025$3,995.00Hematology Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More - 
                
                    
                    Genitourinary Collaboration and Licensing Deals 2016-2025October 2025$3,995.00Genitourinary Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More - 
                
                    
                    Psychiatry Collaboration and Licensing Deals 2019-2025October 2025$3,995.00Psychiatry Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals | Comprehensive deal directory 2019 to 2025
Learn More - 
                
                    
                    Metabolic Collaboration and Licensing Deals 2019-2025October 2025$3,995.00Metabolic Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals | Comprehensive deal directory 2019 to 2025
Learn More - 
                
                    
                    Cancer Monoclonal Antibody Collaboration and Licensing Deals 2016-2025May 2025$3,995.00Cancer Monoclonal Antibody Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More - 
                
                    
                    Infectious Diseases Collaboration and Licensing Deals 2019-2025October 2025$3,995.00Infectious Diseases Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals | Comprehensive deal directory 2019 to 2025
Learn More - 
                
                    
                    Oncology Collaboration and Licensing Deals 2020-2025October 2025$4,995.00Oncology Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals | Comprehensive deal directory 2020 to 2025
Learn More - 
                
                    
                    Infectious Vaccine Collaboration and Licensing Deals 2016-2025May 2025$3,995.00Infectious Vaccine Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More - 
                
                    
                    Current Partnering Knowledge CenterOctober 2025$14,995.00The All In One Partnering Intelligence Platform
Get unlimited access to our partnering report library conveniently and easily, while maximizing your time and budget
Learn More - 
                
                    
                    Cancer Diagnostic Collaboration and Licensing Deals 2018-2025May 2025$3,995.00Cancer Diagnostic Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2018 to 2025
Learn More 
